PATENT CLAIM ANALYSIS

Application Number: 16117375
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-01
Patent Classification: ["514", "648000"]

Abstract:
An oral dosage form to deliver diphenhydramine through the sublingual or buccal mucosa. The oral dosage form can contain diphenhydramine, or a pharmaceutically acceptable salt thereof, a permeability enhancer, and a buffering agent. The buffering agent can achieve a pH of about 7.0 to about 8.0. The diphenhydramine can completely dissolve within about 2 minutes.

Claim (Index 15):
The method of  claim 12  wherein the disintegrant is selected from the group consisting of crospovidone, sodium starch glycolate, crosslinked sodium carboxymethyl cellulose, low substituted hydroxypropylcellulose, guar gum, sodium alginate, and mixtures thereof.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.58974
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14973759', '15823636', '15387317', '14697891', '12638070']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.793526473905698
- 35 USC 102 Novelty (BERT): 0.5052088528265807
- Combined Prediction Score: 0.7646947117977863
- Mean Citation Score: 215.47927400000003
- Max Citation Score: 270.94516
- Similarity Product: 196.0688617111564

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test